COMP <GO>
GNLX vs PMN // FREE CASH FLOW YIELD
Genelux Corporation (NASDAQ) VS. ProMIS Neurosciences Inc. (ON) (NASDAQ) • 15-METRIC TALLY: GNLX 2
— PMN 1
■ METRIC PARITY
LAST: $2.08 (-0.95%) • MKT CAP: $95.0M
fcf-yield
—
LAST: $3.31 (-70.13%) • MKT CAP: $99.4M
fcf-yield
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (GNLX VS. PMN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | GNLX | PMN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 0.00% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 1/9 | +1.00 | GNLX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 40.1 | 26.6 | +13.45 | GNLX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $95.0M | $99.4M | -$4.3M | PMN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | GNLX REV | PMN REV | GNLX GROSS % | PMN GROSS % | GNLX FCF | PMN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $8.0K | $0 | — | — | -$26.4M | -$28.1M |
| FY 2024 | $8.0K | $0 | — | — | -$21.6M | -$27.2M |
| FY 2023 | $170.0K | $0 | — | — | -$20.3M | -$10.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
GNLX // BETA —
PMN // BETA —